AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 2, 1998, Pages 425-434

  Kuizinga, Marti C ^a   Smits, Jos F M ^a   Arends, Jan W ^a   Daemen, Mat J A P ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

AT receptor; Cardiac function; Endothelium; Fibroblast; Insterstitium; Rat

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DNA; RECEPTOR SUBTYPE; SAPRISARTAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; BENZOFURAN DERIVATIVE; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENDOTHELIUM CELL; FIBROBLAST; HEART; HEART FUNCTION; HEART INFARCTION; HEART OUTPUT; HEART STROKE VOLUME; HEART VENTRICLE SEPTUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; ANIMAL; BIOSYNTHESIS; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM; HEART MUSCLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; BENZOFURANS; CARDIAC OUTPUT; CELL DIVISION; DNA; ENDOTHELIUM; FIBROBLASTS; IMIDAZOLES; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; STROKE VOLUME;

EID: 0031992392     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0607     Document Type: Article

References (60)

1. ANVERSA P, CAPASSO JM, 1991. Loss of intermediate-sized coronary arteries and capillary proliferation after left ventricular failure in rats. Am J Physiol 260: H1552-H1560.
2. ANVERSA P, SONNENBLICK EH, 1990. Ischemic cardiomyopathy: pathophysiologic mechanisms. Prog Cardiovasc Dis 33: 49-70.
3. ANVERSA P, BEGHI C, KIKKAWA Y, OLIVETTI G, 1985. Myocardial response to infarction in the rat. Morphometric measurements of infarct size and myocyte cellular hypertrophy. Am J Pathol 118: 484-492.
4. ANVERSA P, BEGHI C, KIRKKAWA Y, OLIVETTI G, 1986. Myocardial infarction in rats. Infarct size, myocyte hypertrophy and capillary growth. Circ Res 58: 26-37.
5. ASANO K, DUTCHER DL, PORT JD, MINOBE WA, TREMMEL KD, RODEN RL, BOHLMEYER TJ, BUSH EW, JENKIN MJ, ABRAHAM WT, RAYNOLDS MV, ZISMAN LS, PERRYMAN MB, BRISTOW MR, 1997. Selective downregulation of the angiotensin II AT1-receptor in failing human myocardium. Circulation 95: 1193-2000.
6. BOOZ GW, BAKER KM, 1996. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 28: 635-640.
7. BRILLA CG, WEBER KT, 1992. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 120: 893-901.
8. CAPASSO JM, LI P, MEGGS LG, HERMAN MV, ANVERSA P, 1994. Efficacy of angiotensin-converting enzyme inhibition and AT1 receptor blockade on cardiac pump performance after myocardial infarction in rats. J Cardiovasc Pharmacol 23: 584-593.
9. CHANG RS, LOTTI VJ, 1991. Angiotensin receptor subtypes in rat, rabbit and monkey tissues: relative distribution and species dependency. Life Sci 49: 1485-1490.
10. CLEUTJENS JPM, VERLUYTEN MJA, SMITS JFM, DAEMEN MJAP, 1995. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 147: 325-338.
11. DAEMENMJAP, SMITS JFM, 1995. Wound healing response after myocardial infarction: structural and pharmacologic aspects. In: Weber KT (ed.). Wound Healing in cardiovascular disease. Arnonk, NY: Futura Publishing Company Inc., 23-33.
12. DAEMEN MJAP, URATA H, 1997. Healing human myocardial infarction associated with increased chymase immunoreactivity. In: Hearts and Vessels, suppl. 12. Proc of the International Session at the 61st Annual Scientific Meeting of the Japanese Circulation Society "Circulation 97": Springer-Verlag Tokyo 113-115.
13. DE CARVALHO FRIMM C, SUN Y, WEBER KT, 1996. Wound healing following myocardial infarction in the rat: a role for bradykinin and prostaglandins. J Mol Cel Cardiol 28: 1279-1285.
14. DE CARVALHO FRIMM C, SUN Y, WEBER KT, 1997. Angiotensin II receptor blockade and myocardial fibrosis of the rat heart. J Lab Clin Med 129: 439-446.
15. FISHBEIN MC, MACLEAN D, MAROKO PR, 1978. Experimental myocardial infarction in the rat. Am J Pathol 90: 57-70.
16. DE GASPARO M, BOTTARI S, LEVENS NR, 1995. Characteristics of angiotensin II receptors and their role in cell and organ physiology. In: Laragh JH and Brenner BM (eds). Hypertension: pathophysiology, diagnosis and management, second ed. New York: Raven Press Ltd, 1695-1720.
17. GRADY EF, SECHI LA, GRIFFIN CA, SCHAMBELAN M, KALINYAK JE, 1991. Expression of AT2 receptors in the developing rat fetus. J Clin Invest 88: 921-933.
18. HAYWOOD GA, GULLESTAD L, KATSUYA T, HUTCHINSON HG, PRATT RE, HORIUCHI M, FOWLER MB, 1997. AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation 95: 1201-1206.
19. HUDLICKA O, 1991. What makes blood vessels grow? J Physiol (London) 444: 1-24.
20. IWAI N, SHIMOIKE H, KINOSHITA M, 1995. Cardiac renin angiotensin system in the hypertrophied heart. Circulation 92: 2690-2696.
21. KEISER JA, PANEK RL, 1994. Pharmacology of AT2 receptors. In: Saavedra JM and Timmermans PBMWM (eds). Angiotensin Receptors. New York: Plenum Press, 135-149.
22. KLINGE O, STOCKER E, 1968. Die DNA-Synthese im Rattenherzen als Funktion des Lebensalters. Autoradiographische Untersuchungen mit 3H-Thymidin. Experientia 24: 167-168.
23. LEVY BI, HEYMES C, CAPUTO L, BENESSIOANO J, POITEVIN P, DURIEZ M, SAMUEL JW, 1996. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on rat vascular tissue. J Clin Invest 98: 418-425.
24. LOPEZ JJ, LORELL BH, INGELFINGER JR, WEINBERG EO, SCHUNKERTH, DIAMANT D, TANG S-S, 1994. Distribution and function of cardiac angiotensin AT1-and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol 267: H844-H852.
25. MACARI D, WHITEBREAD S, CUMIN F, DE GASPARO M, LEVENS N, 1994. Renal actions of the AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system. Eur J Pharmacol 259: 27-36.
26. MARTORANA P, KETTENBACH B, BREIPOHL G, LINZ W, SCHOLKENS B, 1990. Reduction of infarct size by local angiotensin converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol 182: 395-396.
27. MEGGS LG, COUPET J, HUANG H, CHENG W, LI P, CAPASSO JM, HOMCY CJ, ANVERSA P, 1993. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ Res 72: 1149-1162.
28. MICHEL JB, LATTION AL, SALZMANN JL, CEROL ML, PHILIPPE M, CAMILLIERI JP, CORVOL P, 1988. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 62: 641-650.
29. NAKAJIMA M, HUTCHINSON HG, FUJINAGA M, HAYASHIDA W, MORISHITA R, ZHANG L, HORIUCHI M, PRATT RE, DZAU VJ, 1995. The angiotensin II type 2 (AT2) receptor antagonizes the growth effect of the AT1 receptor: gain of function study using gene transfer. Proc Natl Acad Sci USA 92: 10663-10667.
30. NELISSEN-VRANCKEN HJ, DEBETS JJ, SNOECKX LH, DAEMEN MJAP, SMITS JFM, 1996. Time-related normalization of maximal coronary flow in isolated perfused hearts of rats with myocardial infarction. Circulation 93: 349-355.
31. NIO Y, MATSUBARA H, MURASAWA S, KANASAKI M, INADA M, 1995. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 95: 46-54.
32. OLIVETTI G, LAGRASTA C, RICCI R, SONNENBLICK EH, CAPASSO JM, ANVERSA P, 1989. Long-term pressure-induced cardiac hypertrophy: capillary and mast cell proliferation. Am J Physiol 257: H1766-H1772.
33. PASSIER RCCJ, SMITS JFM, VERLUYTEN MJA, STUDER R, DREXLER H, DAEMEN MJAP, 1995. Activation of angiotensin converting enzyme expression in the infarct zone following myocardial infarction. Am J Physiol 269: H1268-H1271.
34. PASSIER RCCJ, SMITS JFM, VERLUYTEN MJA, DAEMEN MJAP, 1996. Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. Am J Physiol 271: H1040-H1048.
35. PFEFFER JM, FISCHER TA, PFEFFER MA, 1995. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu Rev Physiol 57: 805-826.
36. PIERUZZI F, ABASSI ZA, KEISER HR, 1995. Expression of renin angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation 92: 3105-3112.
37. PITT B, SEGAL R, MARTINEZ FA, MEURERS G, COWLEY AJ, THOMAS I, DEEDWANIA PC, SANVELY DB, CHANG PI, 1997. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349: 747-752.
38. REGITZ-ZAGROSEK V, FRIEDEL N, HEYMANN A, BAUER P, NEUSS M, ROLFS A, STEFFEN C, HILDEBRANDT A, HETZER R, FLECK E, 1995. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 91: 1461-1471.
39. ROBERT V, SILVESTRE JS, CHARLEMANGNE D, SABRI A, TROUVE P, WASSEF M, SWYNGEDAUW B, DELCRAYE C, 1995. Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension 26: 971-978.
40. ROGG H, DE GASPARO M, GRAEDEL E, STULZ P, BURKART F. EBERHARD M, ERNE P, 1996. Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur Heart J 17: 1112-1120.
41. SADOSHIMA J, IZUMO S, 1993. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73: 413-423.
42. SCHIEFFER B, WIRGER A, MEYBRUNN M, SEITZ S, HOLTZ R, REIDE UN, DREXLER H, 1994. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodelling after myocardial infarction in the rat. Circulation 89: 2273-2282.
43. SCHOEMAKER RG, URQUHART J, DEBETS JJ, STRUYKER-BOUDIER HA, SMITS JF, 1990. Acute hemodynamic effects of coronary artery ligation in conscious rats. Basic Res Cardiol 85: 9-20.
44. SCHOEMAKER RG, DEBETS JJ, STRUYKER-BOUDIER HA, SMITS JF, 1991. Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction. J Mol Cell Cardiol 23: 187-197.
45. SECHI LA, GRIFFIN CA, GRADY EF, KALINYAK JE, SCHAMBELAN M, 1992. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res 71:1482-1489.
46. SMITS JFM, VAN KRIMPEN C, SCHOEMAKER RG, CLEUTJENS JPM, DAEMEN MJAP, 1992. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis and interstitial collagen content. J Cardiovasc Pharmacol 20: 772-778.
47. STOLL M, STECKELINGS M, PAUL M, BOTTARI SP, METZGER R, UNGER T, 1995. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95: 651-657.
48. SUN, Y, WEBER KT, 1996a. Angiotensin converting enzyme and myofibroblasts during tissue repair in rat heart. J Mol Cell Cardiol 28: 851-858.
49. SUN Y, WEBER KT, 1996b. Cells expressing angiotensin II receptors in fibrous tissue of the heart. Cardiovasc Res 31: 518-525.
50. SUZUKI J, MATSUBARA H, URAKAMI M, INADA M, 1993. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 73: 439-447.
51. TOMANEK RJ, HOVANEC JM, 1981. The effects of long-term pressure-overload and aging on the myocardium. J Mol Cell Cardiol 13: 471-488.
52. TOMANEK RJ, WESSEL TJ, HARRISON DG, 1991. Capillary growth and geometry during long-term hypertension and myocardial hypertrophy in dogs. Am J Physiol 261: H1011-H1018.
53. VAN-KRIMPEN C, SCHOEMAKER RG, CLEUTJENS JPM, SMITS JFM, STRUYKER-BOUDIER HAJ, BOSMAN FT, DAEMEN MJAP, 1991a. Angiotensin I converting enzyme inhibitors and cardiac remodeling. Basic Res Cardiol 86 (Suppl. 1): 149-155.
54. VAN-KRIMPEN C, SMITS JF, CLEUTJENS JP, DEBETS JJ, SCHOEMAKER RG, STRUYKER-BOUDIER HA, BOSMAN FT, DAEMEN MJ. 1991b. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol 23: 1245-1253.
55. VOLDERS PGA, WILLEMS IEMG, CLEUTJENS JPM, ARENDS JW, HAVENITH MG, DAEMEN MJAP, 1993. Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol 25: 317-323.
56. WALLENSTEIN S, ZUCKER CL, FLEISS JL, 1980. Some statistical methods useful in circulation research. Circ Res 47:1-9.
57. WEBER K, 1989. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13: 1637-1652.
58. WOLLERT KC, STUDER R, DOERFER K, SCHIEFFER E, HOLUBARSCH C, JUST H, DREXLER H, 1992. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Circulation 95: 1910-1917.
59. ZIMMERMAN R, ARRAS M, ULMANN C, STRASSER R, SACK S, MOLLNAU H, SCHAPER J, SCHAPER W, 1997. Time course of mitosis and collateral growth following coronary microembolization in the porcine heart. Cell Tissue Res 287: 583-590.
60. ZHOU J, ERNSBERGER P, DOUGLAS JG, 1993. A novel angiotensin receptor subtype in rat mesangium. Hypertension 21: 1035-1038.